Ninlaro 3 mg capsules contain 3 mg of ixazomib equivalent to 4. See 17 for patient counseling information and fdaapproved. The recommended starting dose of revlimid is 25 mg once daily on days 121 of repeated 28day cycles. The dose may need to be reduced in the elderly or if steroidrelated. Use an alternative to a strong or moderate cyp3a inhibitor in patients who are taking a reduced dose of. Lenalidomide, sold under the trade name revlimid among others, is a medication used to treat multiple myeloma mm and myelodysplastic syndromes mds.
Extended survival and reduced risk of aml progression in erythroidresponsive lenalidomidetreated. Refer to the dabrafenib prescribing information for recommended dabrafenib dosing information. Revlimid lenalidomide is a prescription medicine, used to treat adults with multiple myeloma mm in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation a type of stem cell transplant that uses your own stem cells. For the most recent pi, please refer to the tga website at. Lenalidomide safety data sheet supersedes revision. Tap along the timeline to move to different parts of the audio file.
Disease trajectory is characterized by malignant transformation with serial cycles of response, remission, and relapse in the presence of treatment. Revlimid is a thalidomide analogue indicated for the treatment of adult patients with. Download leaflet view the patient leaflet in pdf format. In studies of both healthy volunteers and subjects with hansens disease, the mean. Highlights of prescribing information these highlights do not include all the information needed to use afinitorafinitor disperz safely and effectively. Revlimid, innlenalidomide european medicines agency. See full prescribing information for afinitorafinitor disperz. Lenalidomide crossed the placenta after administration to pregnant rabbits and pregnant rats see data. Light pink gelatin capsule imprinted with takeda on the cap and 2.
Lenalidomide, an analog of thalidomide, is an immunomodulatory agent with multiple actions. It is a more potent molecular analog of thalidomide, which inhibits tumor angiogenesis, tumorsecreted cytokines, and tumor proliferation through induction of apoptosis. Tell all of your health care providers that you take lenalidomide. Sep 26, 2019 the ongoing phase 2 portion with 20 mg lenalidomide will provide a more robust efficacy assessment at this dose. For concomitant therapy doses, see full prescribing information 2. The phase 1b doseescalation portion, presented here, aimed to establish the maximum tolerated dose and evaluate the safety and tolerability of ibrutinib plus lenalidomide and rituximab in transplantineligible patients with relapsedrefractory dlbcl.
The starting dose of lenalidomide is 25 mg orally once daily on days 1 to 21. See 17 for patient counseling information and fda approved patient. Daratumumab intravenous infusion on days 1, 8, 15, and 22 of cycles 1 and 2, then days 1 and 15 of cycles 3 through 6, then monthly thereafter. Please see full prescribing information, including boxed warnings and medication guide, for. Daratumumab plus pomalidomide and dexamethasone in relapsed. Highlightsof prescribing information kyprolis safely and. Worldwide, multiple myeloma has an incidence of more than 114,000 cases and causes almost 80,000 deaths annually. Rvd or vrd is given to alleviate myeloma symptoms and slow the progression of multiple myeloma, not to cure this disease. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential risk to a fetus. Highlights of prescribing information these highlights do not. Oct 16, 2019 tell all of your health care providers that you take lenalidomide. On february 22, the food and drug administration fda approved a new use for the drug lenalidomide revlimid in treating patients with multiple myeloma under the new approval, patients with multiple myeloma can receive lenalidomide as maintenance therapy after receiving an autologous stem cell transplant for the disease, to help keep the cancer from coming back.
Data sources include ibm watson micromedex updated 10 apr 2020, cerner multum updated 6 apr 2020. Nov 07, 2019 lenalidomide caused thalidomidetype limb defects in monkey offspring. However, the capsules are 90% bioavailable relative to an oral peg solution. If you are a man, do not donate sperm while using lenalidomide and for 1 month after stopping. It is used to treat multiple myeloma, certain types of lymphoma, and some myelodysplastic syndromes that cause severe anemia requiring. Material may be irritating to the mucous membranes and upper respiratory tract. Lenalidomide was considered as a potential source of the liver function test abnormalities and discontinued. Lenalidomide approved as firstline therapy in multiple myeloma. In combination with the medicines lenalidomide and dexamethasone in people with newly diagnosed multiple myeloma who cannot receive a type of stem cell transplant that uses their own stem cells autologous stem cell transplant and in people who have received at. Tourmaline mm1 clinical trial results ninlaro ixazomib. Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. Lenalidomide 25 mg by mouth daily for 21 days continuously on days 1 21. Kyprolis 10minute infusion in combination with lenalidomide and dexamethasone. Ibrutinib plus lenalidomide and rituximab has promising.
Click on the revlimid lenalidomide package insert below for reported side effects and possible drug interactions. Lenalidomide is effective at inducing a complete or very good partial response and improves progressionfree survival. These highlights do not include all the information needed to use. Revlimid lenalidomide now fda approved as firstline. Lenalidomide, a thalidomide analogue, caused limb abnormalities in a developmental monkey study.
For mm it is used after at least one other treatment and generally together with dexamethasone. Epd dosing and administration empliciti elotuzumab. If neutropenia is the only toxicity at any dose level, add granulocyte colony stimulating. Lenalidomide inhibits proliferation and induces apoptosis of certain hematopoietic tumor cells including multiple myeloma, mantle cell lymphoma, and del 5q myelodysplastic syndromes in vitro. On february 18, 2015, the us food and drug administration fda approved a new indication for lenalidomide revlimid. Lenalidomideinduced severe hepatotoxicity blood american. Find patient medical information for lenalidomide oral on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Pdf pomalidomide, bortezomib and lowdose dexamethasone. Jul 11, 2019 provides accurate and independent information on more than 24,000 prescription drugs, overthecounter medicines and natural products. Further evaluation included an abdominal sonogram that showed mild hepatomegaly 16. The empirical formula for thalidomide is ch10n2o4 and the gram molecular weight is 258. In this study n 45, orr with the triplet of ibrutinib, lenalidomide, and rituximab was 38% and 44% in the overall population and responseevaluable patients, respectively. Lenalidomide is an analogue of thalidomide with immunomodulatory, antiangiogenic, and antineoplastic properties.
Lenalidomide caused thalidomidetype limb defects in monkey offspring. Darzalex is a cd38directed cytolytic antibody indicated for the treatment of adult patients with multiple myeloma 1. This phase 1 doseescalation study evaluated pomalidomide, bortezomib subcutaneous sc or intravenous iv and lowdose dexamethasone lodex in. Highlights of prescribing information perforation can occur. Administration kyprolis can be administered in a 50ml or 100ml intravenous bag of 5% dextrose injection, usp.
After discontinuation of a moderate cyp3a inhibitor, resume previous dose of cotellic 60 mg see drug interactions 7. The recommended dose of dexamethasone is 40 mg once daily on days 14, 912, and 1720 of each 28day cycle for the first 4 cycles of therapy and then 40 mg once daily orally on days 14 every 28 days. Efficacy and safety of ixazomib plus lenalidomidedexamethasone ird vs placebord in patients with relapsedrefractory multiple myeloma by cytogenetic risk status in the global phase 3 tourmalinemm1 study. The recommended starting dose of revlimid is 25 mgday orally on days 121 of repeated 28day. New use for lenalidomide in multiple myeloma national. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in. Dexamethasone dose may depend upon your doctors recommendation. Please see indication and important safety information. This emedtv page takes a look at what else the drug is used for and explains how it works. Lenalidomide, a thalidomide analogue, caused limb abnormalities in a developmental monkey study similar to birth defects caused by. Lenalidomide is also approved for the treatment of patients with mantlecell lymphoma that has relapsed or progressed after 2 therapies, one of which included bortezomib.
It selectively inhibits secretion of inflammatory cells, enhances the activity of immunity. Healthrelated qualityoflife results from the openlabel, randomized, phase iii aspire trial evaluating carfilzomib, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in patients with relapsed multiple myeloma. Are you looking for a place to get your revlimid lenalidomide medication at an affordable price. Do not donate blood while using lenalidomide and for 1 month after stopping. Aug 24, 2017 daratumumab, a human monoclonal antibody targeting cd38, is approved as a monotherapy for the treatment of patients with heavily treated mm 35 and in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with mm who have received. Multiple myeloma disease trajectory kyprolis carfilzomib. Infuse over 10 or 30minutes depending on the kyprolis dose regimen see dosage and administration 2. Lenalidomide 25 mg is taken orally on days 121 and dexamethasone 40 mg by mouth or intravenously on days 1, 8, 15, and 22 of the 28day cycles. Revlimid lenalidomide is a prescription medicine approved in combination with dexamethasone to treat patients with multiple myeloma a type of cancer of the bone marrow who already have had.
Report any suspected fetal exposure to lenalidomide to the fda via the medwatch program at 1800fda1088 and also to the manufacturer at 18884235436. The absolute bioavailability of thalidomide from thalomid thalidomide capsules has not yet been characterized in human subjects due to its poor aqueous solubility. Darzalex is a prescription medicine used to treat adults with multiple myeloma. Revlimid lenalidomide dosing, indications, interactions. Because of the potential for adverse reactions in breastfed infants from lenalidomide, advise women not to breastfeed during treatment. Lenalidomide is a chemotherapy drug that targets specific proteins within cancer cells and stops the cancer cell from growing. Prescription hope is a nationally recognized prescription medication access program, headquartered in columbus.
After treatment, patients who respond to rvd typically are either monitored, continue on to maintenance therapy, or proceed to bone marrow transplant. A treatment option for multiple myeloma revlimid lenalidomide. Lenalidomide, a thalidomide analogue, caused limb abnormalities in a developmental monkey study similar to birth defects caused by thalidomide in humans. Nphthalimido glutarimide, is an immunomodulatory agent.
If lenalidomide is used during pregnancy, it may cause birth defects or death to a developing baby. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Afinitor everolimus tablets, for oral use afinitor disperz everolimus tablets for oral suspension. This includes your doctors, nurses, pharmacists, and dentists. If lenalidomide is used during pregnancy, it may cause birth defects or embryofetal death. Efficacy and safety of ixazomib plus lenalidomidedexamethasone ird vs placebord in patients with relapsedrefractory multiple myeloma by cytogenetic risk status in the global phase 3. See dosing information for empliciti elotuzumab treatment administered as a component of the epd regimen. It is used to treat multiple myeloma, certain types of lymphoma, and some myelodysplastic syndromes that cause severe anemia requiring blood transfusions. The new drug application nda is the vehicle in the united states through which drug sponsors formally propose that the fda approve a new pharmaceutical for sale and marketing. Pregnancy must be excluded before start of treatment. May be harmful by inhalation, ingestion, or skin absorption.
The solubility of lenalidomide in water and at ph 1. Corporation at 18884235436 or fda at 1800fda1088 or. Common side effects include diarrhea, itchiness, join pain, fever, headache, and trouble sleeping. Refer to the dexamethasone and lenalidomide prescribing information for additional. Thalidomide is a known human teratogen that causes severe lifethreatening human birth defects. Rvd or vrd treatment for multiple myeloma chemoexperts. You may report side effects to the fda at 1800fda1088. Data on file 121, takeda pharmaceuticals international co. Celgene, expanding its use, in combination with lowdose dexamethasone, for the firstline treatment of patients with newly diagnosed multiple myeloma.
1462 1234 109 32 577 809 1373 1100 442 1558 1541 570 692 10 243 341 737 544 1300 371 1527 1207 393 1478 735 258 668 429 733 469 1154 431 1461 1429 84 295 289